AFDO RAPS Healthcare Products Collaborative
Presents
2024 Combo Logo FDA
Register now

Speakers & Moderators

The Combination Products Summit speakers are handpicked by the Combination Products Summit Strategic Committee to deliver purpose-driven content that dives below the surface, challenge status quo, engage attendees in collaborative dialogue, and provide practical information that can be implemented. Our speakers are thought leaders who are sure to facilitate insightful discussion.

Khaudeja
Bano

Amgen

Vice President, Combination Product Quality

Kim
Belsky

AFDO/RAPS Healthcare Products Collaborative

Strategic Facilitator for MedCon and Combination Products Summit

Ryan
Hoshi

AbbVie

Director, Regulatory Policy and Intelligence

Jason
Lipman

Sanofi

Senior Director, Global Regulatory Affairs, Device and Combination Products

Patricia
Love

FDA

Deputy Director, Office of Combination Products

Annette
Marthaler

FDA

Senior Regulatory Counsel, Office of Combination Products

Ryan
McGowan

AstraZeneca

Director, Digital Devices and Combination Products

Hemal
Mehta

Johnson & Johnson

Associate Director, Global CMC-Regulatory Affairs, Medical Devices and Combination Products

Susan
Neadle

Combination Products Consulting

Principal Consultant & President

Andrea
Redd

Eli Lilly

Associate Vice President, Global Regulatory Affairs, Drug Delivery & Combination Products

Tine
Schroder-Albeck

ALK A/S

Senior Quality Assurance Professional

Stephanie
Shapley

FDA

Senior Advisor, Office of Combination Products

Chin-Wei
Soo

Genentech

Global Regulatory Head – Devices and Combination Products

James
Wabby

AbbVie

Global Head – Emerging Technologies, Combination Products, and Devices

Rumi
Young

Novo Nordisk

Director, Regulatory Policy

More speakers will be added soon!

This conference IS co-sponsored by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services. The contents are those of the presenters and do not necessarily represent the official views of, nor an endorsement by, FDA/HHS or the U.S. government.

The AFDO/RAPS Healthcare Products Collaborative is a joint venture established in 2022 between the Association of Food and Drug Officials and the Regulatory Affairs Professionals Society. Learn more.

Newsletter

Stay in the know about upcoming events and breaking news from the collaborative.

Subscribe

ContACT

Have questions about our events or how to get involved with one of our committees or workgroups?

Get in touch

© 2024 AFDO/RAPS Healthcare Products Collaborative